Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery

NCT00905450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract
Inflammation

Interventions

DRUG: BOL-303242-X
DRUG: Vehicle for BOL-303242-X

Sponsor

Bausch & Lomb Incorporated